ATS 2024 Final Program

Click on the session title to view the speakers

163

MONDAY • MAY 20

P130 Clinical, Hemodynamic, and Genetic Characteristics of Human Immunodeficiency Virus Associated Pulmonary Arterial Hypertension: A Retrospective Analysis of the National Biological Sample and Data Repository for Pulmonary Arterial Hypertension P131 Representativeness of Clinical Trial Criteria in the Real World Pulmonary Arterial Hypertension (PAH) P132 Survival Among US Veterans With Pulmonary Hypertension Between 2003-2015 Based on Hemodynamic Profile P133 Racial Disparities in Hospitalization for Group 1 Pulmonary Arterial Hypertension: A Nationwide Analysis P134 Association of Race With Outcomes in Patients With Acute Pulmonary Embolism Requiring Interhospital Transfer: A Retrospective, Observational Study P135 Race Is Not Associated With Survival in a Large Cohort of US Veterans Diagnosed With Pulmonary Hypertension Between 2003-2015 P136 Disparity in Pulmonary Embolism Outcomes Amongst Asians P137 Sex-Based Differences in Acute Pulmonary Embolism Severity P138 History of Adverse Pregnancy Outcomes in Women With Pulmonary Arterial Hypertension: A Single Center Pilot Study P139 Morbidity and Mortality of Patients With Pulmonary Arterial Hypertension in a Reference Center in Brazil P140 Evaluation of Risk Score Tools to Predict Mortality in Hispanic Patients With Acute Pulmonary Embolism P141 Racial Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolism P142 Experience of a Large Urban Public Safety Net Hospital With Pulmonary Hypertension Class 1 and 4 P143 Profile of Patients Anticoagulated Over a Period of One Year in the Respiratory Unit of Federal Medical Centre, Owerri

P1327 Pulmonary Veno-Occlusive Disease in a Patient Without Clear Risk Factors: A Case Report P1328 Maintaining Hemodynamic Stability by Preserving Severe Pulmonary Hypertension in Setting of Large Pericardial Effusion P1329 Learning in the Catheterisation Laboratory: How Experience of Right Heart Catheterisation Can Improve Trainees Understanding of Pulmonary Hypertension P1330 An Unusual Case of Severe Precapillary Pulmonary Hypertension and Pulmonary Alveolar Proteinosis P1331 Unmasking Pressures: A Case of Pulmonary Hypertension in a Patient With Aortic Coarctation and Recurrent Aortic Valve Surgeries P1332 Possible Methotrexate Induced Pulmonary Hypertension in a Patient With Crohn’s Disease P1333 Shunt’s the Matter? P1334 The Silent Progression: From Autoimmune Hepatitis to Life-Threatening Pulmonary Hypertension P1335 From Underestimated Echocardiographic Pulmonary Artery Pressure to Fatal Pulmonary Hypertension: A Diagnostic Challenge P1336 Tadalafil Improves Exercise Induced Pulmonary Arterial Hypertension in a Patient With Chronic Altitude-Related Illness

BEHAVIORAL • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B59 DEFINING DISPARITIES IN

PULMONARY VASCULAR DISEASES

9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area B (Hall A-B2, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees

ATS 2024 Conference Program • San Diego, CA